How many stem-cell trials for Arterial Hypertension are recruiting right now?
As of 2026-08-29: 5 open studies against 35 registrations overall, or 14% of the historical total.
Who these studies will actually take
Trials generally require documented resistance — uncontrolled pressure despite three agents including a diuretic — plus ambulatory monitoring to exclude white-coat effect. People whose pressure is simply untreated or intermittently treated will not qualify, and that covers most of the people who go looking.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT07119580 — Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma | n/a | Recruiting | 90 | National Taiwan University Hospital | 2025-07-08 |
| NCT07613099 — Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging | Phase 3 | Recruiting | 210 | National Heart, Lung, and Blood Institute (NHLBI) | 2026-09-02 |
| NCT03630211 — Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis | Phase 2 | Recruiting | 8 | Paul Szabolcs | 2018-07-31 |
| NCT03011541 — Stem Cell Ophthalmology Treatment Study II | n/a | Recruiting | 500 | MD Stem Cells | 2016-01 |
| NCT07183384 — MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction | Phase 1, Phase 2 | Recruiting | 80 | Universitas Padjadjaran | 2024-07-01 |
What recruiting does and does not mean
The status field tracks paperwork, not promise. What matters underneath it is the eligibility list, the outcome measures the sponsor committed to, and whether a site near you is actually enrolling, all of which sit on the registry record itself.
Sites sit in 13 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Zhejiang University — 3 registered records
- Mayo Clinic — 2 registered records
- National Heart, Lung, and Blood Institute (NHLBI) — 2 registered records
- MD Stem Cells — 2 registered records
- Wenzhou Medical University — 1 registered record
- Federal University of Pelotas — 1 registered record
Frequently asked
How many stem-cell trials for Arterial Hypertension are recruiting right now?
5 of 35 registered records (2026-08-29).
Can I join one of these trials?
That depends entirely on the written criteria — age, disease stage, prior treatment and often geography. The site's study coordinator is the only reliable source on current capacity.
Do trials charge participants?
Participants are not usually billed for the study product. A five-figure invoice attached to a supposed trial place means you are buying a treatment, not joining research.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Arterial Hypertension: cell-therapy evidence and registered trials
- How much does stem cell therapy for Arterial Hypertension cost? (2026)
- Arterial Hypertension stem cell therapy — your questions answered (2026)
- Arterial Hypertension: cell-therapy evidence by therapy class
- MSC vs exosomes for Arterial Hypertension: what the registries show